These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 25632068)

  • 1. The AURKA/TPX2 axis drives colon tumorigenesis cooperatively with MYC.
    Takahashi Y; Sheridan P; Niida A; Sawada G; Uchi R; Mizuno H; Kurashige J; Sugimachi K; Sasaki S; Shimada Y; Hase K; Kusunoki M; Kudo S; Watanabe M; Yamada K; Sugihara K; Yamamoto H; Suzuki A; Doki Y; Miyano S; Mori M; Mimori K
    Ann Oncol; 2015 May; 26(5):935-942. PubMed ID: 25632068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aurora A kinase and its activator TPX2 are potential therapeutic targets in KRAS-induced pancreatic cancer.
    Gomes-Filho SM; Dos Santos EO; Bertoldi ERM; Scalabrini LC; Heidrich V; Dazzani B; Levantini E; Reis EM; Bassères DS
    Cell Oncol (Dordr); 2020 Jun; 43(3):445-460. PubMed ID: 32193808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TPX2 and AURKA promote 20q amplicon-driven colorectal adenoma to carcinoma progression.
    Sillars-Hardebol AH; Carvalho B; Tijssen M; Beliën JA; de Wit M; Delis-van Diemen PM; Pontén F; van de Wiel MA; Fijneman RJ; Meijer GA
    Gut; 2012 Nov; 61(11):1568-75. PubMed ID: 22207630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AurkA nuclear localization is promoted by TPX2 and counteracted by protein degradation.
    Asteriti IA; Polverino F; Stagni V; Sterbini V; Ascanelli C; Naso FD; Mastrangelo A; Rosa A; Paiardini A; Lindon C; Guarguaglini G
    Life Sci Alliance; 2023 May; 6(5):. PubMed ID: 36797043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Taxane-mediated radiosensitization derives from chromosomal missegregation on tripolar mitotic spindles orchestrated by AURKA and TPX2.
    Orth M; Unger K; Schoetz U; Belka C; Lauber K
    Oncogene; 2018 Jan; 37(1):52-62. PubMed ID: 28869599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AurkA/TPX2 co-overexpression in nontransformed cells promotes genome instability through induction of chromosome mis-segregation and attenuation of the p53 signalling pathway.
    Naso FD; Polverino F; Cilluffo D; Latini L; Stagni V; Asteriti IA; Rosa A; Soddu S; Guarguaglini G
    Biochim Biophys Acta Mol Basis Dis; 2024 Apr; 1870(4):167116. PubMed ID: 38447882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bcl2l10, a new Tpx2 binding partner, is a master regulator of Aurora kinase A in mouse oocytes.
    Lee SY; Kim EY; Kim KH; Lee KA
    Cell Cycle; 2016 Dec; 15(23):3296-3305. PubMed ID: 27753540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ID1 overexpression promotes HCC progression by amplifying the AURKA/Myc signaling pathway.
    Wu M; Zhou Y; Fei C; Chen T; Yin X; Zhang L; Ren Z
    Int J Oncol; 2020 Sep; 57(3):845-857. PubMed ID: 32705157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glioma pathogenesis-related protein 1 induces prostate cancer cell death through Hsc70-mediated suppression of AURKA and TPX2.
    Li L; Yang G; Ren C; Tanimoto R; Hirayama T; Wang J; Hawke D; Kim SM; Lee JS; Goltsov AA; Park S; Ittmann MM; Troncoso P; Thompson TC
    Mol Oncol; 2013 Jun; 7(3):484-96. PubMed ID: 23333597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioinformatics and experimental validation of an AURKA/TPX2 axis as a potential target in esophageal squamous cell carcinoma.
    Du R; Li K; Zhou Z; Huang Y; Guo K; Zhang H; Chen Z; Zhao X; Han L; Bian H
    Oncol Rep; 2023 Jun; 49(6):. PubMed ID: 37083097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TPX2 expression is associated with cell proliferation and patient outcome in esophageal squamous cell carcinoma.
    Hsu PK; Chen HY; Yeh YC; Yen CC; Wu YC; Hsu CP; Hsu WH; Chou TY
    J Gastroenterol; 2014 Aug; 49(8):1231-40. PubMed ID: 23963785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cell cycle-related genes RHAMM, AURKA, TPX2, PLK1, and PLK4 are associated with the poor prognosis of breast cancer patients.
    Kahl I; Mense J; Finke C; Boller AL; Lorber C; Győrffy B; Greve B; Götte M; Espinoza-Sánchez NA
    J Cell Biochem; 2022 Mar; 123(3):581-600. PubMed ID: 35014077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated mRNA Levels of AURKA, CDC20 and TPX2 are associated with poor prognosis of smoking related lung adenocarcinoma using bioinformatics analysis.
    Zhang MY; Liu XX; Li H; Li R; Liu X; Qu YQ
    Int J Med Sci; 2018; 15(14):1676-1685. PubMed ID: 30588191
    [No Abstract]   [Full Text] [Related]  

  • 14. Activation of EIF4E by Aurora Kinase A Depicts a Novel Druggable Axis in Everolimus-Resistant Cancer Cells.
    Katsha A; Wang L; Arras J; Omar OM; Ecsedy J; Belkhiri A; El-Rifai W
    Clin Cancer Res; 2017 Jul; 23(14):3756-3768. PubMed ID: 28073841
    [No Abstract]   [Full Text] [Related]  

  • 15. TPX2 overexpression in medullary thyroid carcinoma mediates TT cell proliferation.
    Yang X; Liu G; Xiao H; Yu F; Xiang X; Lu Y; Li W; Liu X; Li S; Shi Y
    Pathol Oncol Res; 2014 Jul; 20(3):641-8. PubMed ID: 24488334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Boolean modeling identifies Greatwall/MASTL as an important regulator in the AURKA network of neuroblastoma.
    Dahlhaus M; Burkovski A; Hertwig F; Mussel C; Volland R; Fischer M; Debatin KM; Kestler HA; Beltinger C
    Cancer Lett; 2016 Feb; 371(1):79-89. PubMed ID: 26616283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the microtubule-associated protein MAP9/ASAP and its partners AURKA and PLK1 in colorectal and breast cancers.
    Rouquier S; Pillaire MJ; Cazaux C; Giorgi D
    Dis Markers; 2014; 2014():798170. PubMed ID: 24876664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting Aurora kinase-A downregulates cell proliferation and angiogenesis in neuroblastoma.
    Romain C; Paul P; Kim KW; Lee S; Qiao J; Chung DH
    J Pediatr Surg; 2014 Jan; 49(1):159-65. PubMed ID: 24439602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A MYC-aurora kinase A protein complex represents an actionable drug target in p53-altered liver cancer.
    Dauch D; Rudalska R; Cossa G; Nault JC; Kang TW; Wuestefeld T; Hohmeyer A; Imbeaud S; Yevsa T; Hoenicke L; Pantsar T; Bozko P; Malek NP; Longerich T; Laufer S; Poso A; Zucman-Rossi J; Eilers M; Zender L
    Nat Med; 2016 Jul; 22(7):744-53. PubMed ID: 27213815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting AURKA-CDC25C axis to induce synthetic lethality in ARID1A-deficient colorectal cancer cells.
    Wu C; Lyu J; Yang EJ; Liu Y; Zhang B; Shim JS
    Nat Commun; 2018 Aug; 9(1):3212. PubMed ID: 30097580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.